BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Del Buono MG, Arena R, Borlaug BA, Carbone S, Canada JM, Kirkman DL, Garten R, Rodriguez-Miguelez P, Guazzi M, Lavie CJ, Abbate A. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;73:2209-25. [PMID: 31047010 DOI: 10.1016/j.jacc.2019.01.072] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 43.0] [Reference Citation Analysis]
Number Citing Articles
1 Ezzatvar Y, Izquierdo M, Núñez J, Calatayud J, Ramírez-Vélez R, García-Hermoso A. Cardiorespiratory fitness measured with cardiopulmonary exercise testing and mortality in patients with cardiovascular disease: A systematic review and meta-analysis. J Sport Health Sci 2021:S2095-2546(21)00070-3. [PMID: 34198003 DOI: 10.1016/j.jshs.2021.06.004] [Reference Citation Analysis]
2 Ávila MR, Figueiredo PHS, Lima VP, Silva WT, Vianna MVA, Fernandes LHC, de Azevedo ACA, Lima MMO, de Carvalho Bastone A, do Carmo Pereira Nunes M, Mediano MFF, da Costa Rocha MO, Costa HS. Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathy. Trop Med Int Health 2021;26:936-42. [PMID: 33864407 DOI: 10.1111/tmi.13590] [Reference Citation Analysis]
3 Chen C, Huang Y, Zeng Y, Lu X, Dong G. Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 2019;19:311. [PMID: 31870322 DOI: 10.1186/s12872-019-01275-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Del Buono MG, Iannaccone G, Scacciavillani R, Carbone S, Camilli M, Niccoli G, Borlaug BA, Lavie CJ, Arena R, Crea F, Abbate A. Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. Progress in Cardiovascular Diseases 2020;63:570-84. [DOI: 10.1016/j.pcad.2020.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
5 Guimarães GV, Ribeiro F, Castro RE, Roque JM, Machado ADT, Antunes-Correa LM, Ferreira SA, Bocchi EA. Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction. Int J Cardiol 2021;343:73-9. [PMID: 34506822 DOI: 10.1016/j.ijcard.2021.08.050] [Reference Citation Analysis]
6 Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res 2021;117:423-34. [PMID: 32666082 DOI: 10.1093/cvr/cvaa217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
7 Abbate A, Wohlford GF, Del Buono MG, Chiabrando JG, Markley R, Turlington J, Kadariya D, Trankle CR, Biondi-Zoccai G, Lipinski MJ, Van Tassell BW. Interleukin-1 blockade with Anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials. Eur Heart J Cardiovasc Pharmacother 2021:pvab075. [PMID: 34617567 DOI: 10.1093/ehjcvp/pvab075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Kadariya D, Trankle CR, Wohlford G, Buckley L, Del Buono MG, Billingsley H, Viscusi M, Tchoukina I, Shah KB, Arena R, Van Tassell B, Abbate A. Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions. Am J Cardiol 2020;125:76-81. [PMID: 31703805 DOI: 10.1016/j.amjcard.2019.09.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Pugliese NR, De Biase N, Gargani L, Mazzola M, Conte L, Fabiani I, Natali A, Dini FL, Frumento P, Rosada J, Taddei S, Borlaug BA, Masi S. Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol 2020:zwaa129. [PMID: 33624088 DOI: 10.1093/eurjpc/zwaa129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Cai H, Cao P, Zhou W, Sun W, Zhang X, Li R, Shao W, Wang L, Zou L, Zheng Y. Effect of early cardiac rehabilitation on prognosis in patients with heart failure following acute myocardial infarction. BMC Sports Sci Med Rehabil 2021;13:139. [PMID: 34717743 DOI: 10.1186/s13102-021-00368-z] [Reference Citation Analysis]
11 Tucker WJ, Angadi SS, Haykowsky MJ, Nelson MD, Sarma S, Tomczak CR. Pathophysiology of Exercise Intolerance and Its Treatment With Exercise-Based Cardiac Rehabilitation in Heart Failure With Preserved Ejection Fraction. J Cardiopulm Rehabil Prev 2020;40:9-16. [PMID: 31764536 DOI: 10.1097/HCR.0000000000000481] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
12 Pandey A, Keshvani N, Zhong L, Mentz RJ, Piña IL, DeVore AD, Yancy C, Kitzman DW, Fonarow GC. Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure. JACC Heart Fail 2021;9:471-81. [PMID: 33992563 DOI: 10.1016/j.jchf.2021.02.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Müller J, Lichtblau M, Saxer S, Calendo LR, Carta AF, Schneider SR, Berlier C, Furian M, Bloch KE, Schwarz EI, Ulrich S. Effect of Breathing Oxygen-Enriched Air on Exercise Performance in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction: A Randomized, Placebo-Controlled, Crossover Trial. Front Med (Lausanne) 2021;8:692029. [PMID: 34395475 DOI: 10.3389/fmed.2021.692029] [Reference Citation Analysis]
14 Canada JM, Thomas GK, Trankle CR, Carbone S, Billingsley H, Van Tassell BW, Evans RK, Garten R, Weiss E, Abbate A. Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy. Cardiooncology 2020;6:2. [PMID: 32154028 DOI: 10.1186/s40959-020-0058-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Carbone S, Del Buono MG, Ozemek C, Lavie CJ. Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness. Prog Cardiovasc Dis 2019;62:327-33. [PMID: 31442513 DOI: 10.1016/j.pcad.2019.08.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 15.3] [Reference Citation Analysis]
16 Billingsley H, Rodriguez-Miguelez P, Del Buono MG, Abbate A, Lavie CJ, Carbone S. Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty. Nutrients 2019;11:E2849. [PMID: 31766324 DOI: 10.3390/nu11122849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
17 Izumo M, Kuwata S, Ishibashi Y, Suzuki T, Ohara H, Watanabe M, Sato Y, Nishikawa H, Okuyama K, Kamijima R, Takai M, Kou S, Harada T, Akashi YJ. Prognostic impact of transcatheter mitral valve repair in patients with exercise-induced secondary mitral regurgitation. Eur Heart J Cardiovasc Imaging 2021;22:530-8. [PMID: 32856088 DOI: 10.1093/ehjci/jeaa200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Liu Q, Gao J, Deng J, Xiao J. Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure. Front Cardiovasc Med 2020;7:593429. [PMID: 33195482 DOI: 10.3389/fcvm.2020.593429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Canada JM, Park TS, Ravindra K, Chiabrando JG, Del Buono MG, van Wezenbeek J, Trankle CR, Kadariya D, Keen L, Carbone S, Billingsley H, Wohlford GF, Arena R, Van Tassell BW, Abbate A. Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure. J Cardiopulm Rehabil Prev 2022;42:39-44. [PMID: 34793367 DOI: 10.1097/HCR.0000000000000605] [Reference Citation Analysis]
20 Lindgren M, Börjesson M. The importance of physical activity and cardiorespiratory fitness for patients with heart failure. Diabetes Res Clin Pract 2021;176:108833. [PMID: 33895194 DOI: 10.1016/j.diabres.2021.108833] [Reference Citation Analysis]
21 Koroma TR, Samura SK, Cheng Y, Tang M. Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Cardiol Res 2020;11:40-9. [PMID: 32095195 DOI: 10.14740/cr958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 D'Amario D, Migliaro S, Borovac JA, Restivo A, Vergallo R, Galli M, Leone AM, Montone RA, Niccoli G, Aspromonte N, Crea F. Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Front Physiol. 2019;10:1347. [PMID: 31749710 DOI: 10.3389/fphys.2019.01347] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
23 Heizer J, Carbone S, Billingsley HE, VAN Tassell BW, Arena R, Abbate A, Canada JM. Left ventricular concentric remodeling and impaired cardiorespiratory fitness in patients with heart failure and preserved ejection fraction. Minerva Cardiol Angiol 2021;69:438-45. [PMID: 32996304 DOI: 10.23736/S2724-5683.20.05295-0] [Reference Citation Analysis]
24 Yokota T, Kinugawa S, Hirabayashi K, Yamato M, Takada S, Suga T, Nakano I, Fukushima A, Matsushima S, Okita K, Tsutsui H. Systemic oxidative stress is associated with lower aerobic capacity and impaired skeletal muscle energy metabolism in heart failure patients. Sci Rep 2021;11:2272. [PMID: 33500450 DOI: 10.1038/s41598-021-81736-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Dos Santos MR, da Fonseca GWP, Sherveninas LP, de Souza FR, Battaglia Filho AC, Novaes CE, Pereira RMR, Negrão CE, Barretto ACP, Alves MNN. Android to gynoid fat ratio and its association with functional capacity in male patients with heart failure. ESC Heart Fail 2020;7:1101-8. [PMID: 32220062 DOI: 10.1002/ehf2.12657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Lu YA, Chen SW, Lee CC, Wu VC, Fan PC, Kuo G, Chen JJ, Chu PH, Chang SH, Chang CH. Mid-term survival of patients with chronic kidney disease after extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg 2020;31:595-602. [PMID: 33005952 DOI: 10.1093/icvts/ivaa168] [Reference Citation Analysis]
27 Xue JB, Val-Blasco A, Davoodi M, Gómez S, Yaniv Y, Benitah JP, Gómez AM. Heart failure in mice induces a dysfunction of the sinus node associated with reduced CaMKII signaling. J Gen Physiol 2022;154:e202112895. [PMID: 35452507 DOI: 10.1085/jgp.202112895] [Reference Citation Analysis]
28 Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA, Garcia-Ropero A, Mancini D, Pinney S, Macaluso F, Sartori S, Roque M, Sabatel-Perez F, Rodriguez-Cordero A, Zafar MU, Fergus I, Atallah-Lajam F, Contreras JP, Varley C, Moreno PR, Abascal VM, Lala A, Tamler R, Sanz J, Fuster V, Badimon JJ; EMPA-TROPISM (ATRU-4) Investigators. Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol 2021;77:243-55. [PMID: 33197559 DOI: 10.1016/j.jacc.2020.11.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
29 Craighead DH, Heinbockel TC, Hamilton MN, Bailey EF, Macdonald MJ, Gibala MJ, Seals DR. Time-efficient physical training for enhancing cardiovascular function in midlife and older adults: promise and current research gaps. Journal of Applied Physiology 2019;127:1427-40. [DOI: 10.1152/japplphysiol.00381.2019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
30 Chen JH, Wang LL, Tao L, Qi B, Wang Y, Guo YJ, Miao L. Identification of MYH6 as the potential gene for human ischaemic cardiomyopathy. J Cell Mol Med 2021;25:10736-46. [PMID: 34697898 DOI: 10.1111/jcmm.17015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Kirkman DL, Bohmke N, Carbone S, Garten RS, Rodriguez-Miguelez P, Franco RL, Kidd JM, Abbate A. Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies. Am J Physiol Renal Physiol 2021;320:F161-73. [PMID: 33283641 DOI: 10.1152/ajprenal.00437.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Buono MGD, Garmendia CM, Seropian IM, Gonzalez G, Berrocal DH, Biondi-Zoccai G, Trankle CR, Bucciarelli-Ducci C, Thiele H, Lavie CJ, Crea F, Abbate A. Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling. Curr Probl Cardiol 2022;:101215. [PMID: 35460680 DOI: 10.1016/j.cpcardiol.2022.101215] [Reference Citation Analysis]
33 Szabo TM, Frigy A, Nagy EE. Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results. Int J Mol Sci 2021;22:13053. [PMID: 34884857 DOI: 10.3390/ijms222313053] [Reference Citation Analysis]
34 Tran DL, Celermajer DS, Ayer J, Grigg L, Clendenning C, Hornung T, Justo R, Davis GM, d'Udekem Y, Cordina R. The "Super-Fontan" Phenotype: Characterizing Factors Associated With High Physical Performance. Front Cardiovasc Med 2021;8:764273. [PMID: 34950712 DOI: 10.3389/fcvm.2021.764273] [Reference Citation Analysis]
35 Tran DL, Rodrigues C, du Plessis K, Zannino D, Davis GM, Celermajer DS, d'Udekem Y, Cordina R. Decline Is Not Inevitable: Exercise Capacity Trajectory in an Australian and New Zealand Fontan Cohort. Heart Lung Circ 2021;30:1356-63. [PMID: 33745814 DOI: 10.1016/j.hlc.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mendes M. Cardiopulmonary Exercise Test in the Evaluation of Heart Transplant Candidates with Atrial Fibrillation. Arq Bras Cardiol 2020;114:219-21. [PMID: 32215487 DOI: 10.36660/abc.20200051] [Reference Citation Analysis]
37 Saka K, Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Misumi T, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Kimura K, Tamura K, Momomura SI, Matsue Y. Impact of physical performance on exercise capacity in older patients with heart failure with reduced and preserved ejection fraction. Exp Gerontol 2021;156:111626. [PMID: 34780931 DOI: 10.1016/j.exger.2021.111626] [Reference Citation Analysis]
38 do Nascimento DM, Machado KC, Bock PM, Saffi MAL, Goldraich LA, Silveira AD, Clausell N, Schaan BD. Cardiopulmonary exercise capacity and quality of life of patients with heart failure undergoing a functional training program: study protocol for a randomized clinical trial. BMC Cardiovasc Disord 2020;20:200. [PMID: 32334527 DOI: 10.1186/s12872-020-01481-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Taylor BJ, Shapiro BP, Johnson BD. Exercise intolerance in heart failure: The important role of pulmonary hypertension. Exp Physiol 2020;105:1997-2003. [PMID: 32092200 DOI: 10.1113/EP088105] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Billingsley HE, Dixon DL, Canada JM, Kirkman DL, Rotelli B, Kadariya D, Bohmke N, Markley R, Van Tassell BW, Celi FS, Abbate A, Carbone S. Time of eating and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction and obesity. Nutr Metab Cardiovasc Dis 2021;31:2471-3. [PMID: 34112580 DOI: 10.1016/j.numecd.2021.04.018] [Reference Citation Analysis]
41 Pavlovic NV, Gilotra NA, Lee CS, Ndumele C, Mammos D, Dennisonhimmelfarb C, AbshireSaylor M. Fatigue in Persons With Heart Failure: A Systematic Literature Review and Meta-Synthesis Using the Biopsychosocial Model of Health. J Card Fail 2021:S1071-9164(21)00295-5. [PMID: 34329719 DOI: 10.1016/j.cardfail.2021.07.005] [Reference Citation Analysis]
42 Vatner SF, Zhang J, Oydanich M, Berkman T, Naftalovich R, Vatner DE. Healthful aging mediated by inhibition of oxidative stress. Ageing Res Rev 2020;64:101194. [PMID: 33091597 DOI: 10.1016/j.arr.2020.101194] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 17.5] [Reference Citation Analysis]
43 Almeida MP, Montanha T, Marques M, Silva PM, Viamonte S, Ribeiro F, Santos M. Glittre Activities Daily Living Test: Physiological responses in patients with heart failure. Eur J Prev Cardiol 2020:2047487320911173. [PMID: 33611357 DOI: 10.1177/2047487320911173] [Reference Citation Analysis]
44 Zhao X, Hu L, Leng S, Tan RS, Chai P, Bryant JA, Teo LLS, Fortier MV, Yeo TJ, Ouyang RZ, Allen JC, Hughes M, Garg P, Zhang S, van der Geest RJ, Yip JW, Tan TH, Tan JL, Zhong Y, Zhong L. Ventricular flow analysis and its association with exertional capacity in repaired tetralogy of Fallot: 4D flow cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2022;24:4. [PMID: 34980199 DOI: 10.1186/s12968-021-00832-2] [Reference Citation Analysis]
45 Sugimoto T, Barletta M, Bandera F, Generati G, Alfonzetti E, Rovida M, Gnecchi Ruscone T, Rossi A, Cicoira M, Guazzi M. Central role of left atrial dynamics in limiting exercise cardiac output increase and oxygen uptake in heart failure: insights by cardiopulmonary imaging. Eur J Heart Fail 2020;22:1186-98. [PMID: 32352628 DOI: 10.1002/ejhf.1829] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
46 Valle A, Arrarte V, Pinilla JMG, Campuzano R, de Pablo C, Beltrán P, Quintana AG, Almenar L, Bover R, Ortiz C, Fernández R, Castro A, Sanz P, Sanz M, Lambert JL, Miró V, Armengol X, Crespo M, Montiel Á, Recio A, Pereira E, Oria G, Chabbar M, Gómez MI, Alarcón JA, Garza F, Dominguez JCC, Gil CP, Heviá S, Segovia J, Mora J, Gavira JJ, Bello M. Consenso de expertos en la asistencia multidisciplinaria y el abordaje integral de la insuficiencia cardiaca. Desde el alta hospitalaria hasta la continuidad asistencial con primaria. Revista Española de Cardiología Suplementos 2020;20:3-12. [DOI: 10.1016/s1131-3587(20)30018-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Izumida T, Imamura T. The outcome of acute decompensated heart failure stratified by the Norton scale on admission. J Cardiol 2021;77:432-3. [PMID: 33281015 DOI: 10.1016/j.jjcc.2020.11.015] [Reference Citation Analysis]
48 Roh JD, Houstis N, Yu A, Chang B, Yeri A, Li H, Hobson R, Lerchenmüller C, Vujic A, Chaudhari V, Damilano F, Platt C, Zlotoff D, Lee RT, Shah R, Jerosch-Herold M, Rosenzweig A. Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice. Aging Cell 2020;19:e13159. [PMID: 32441410 DOI: 10.1111/acel.13159] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
49 Rethy L, Borlaug BA, Redfield MM, Oh JK, Shah SJ, Patel RB. Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction. J Am Soc Echocardiogr 2021;34:455-64. [PMID: 33359021 DOI: 10.1016/j.echo.2020.12.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Chilton RJ. Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure. Diabetes Obes Metab 2021;23:1215-8. [PMID: 33464709 DOI: 10.1111/dom.14320] [Reference Citation Analysis]
51 Del Punta L, De Biase N, Balletti A, Filidei F, Pieroni A, Armenia S, Mengozzi A, Mazzola M, Di Fiore V, Dini FL, Rosada J, Virdis A, Taddei S, Pugliese NR, Masi S. Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test. High Blood Press Cardiovasc Prev 2022. [PMID: 35107808 DOI: 10.1007/s40292-021-00494-2] [Reference Citation Analysis]
52 Alnuwaysir RIS, Grote Beverborg N, Hoes MF, Markousis-Mavrogenis G, Gomez KA, van der Wal HH, Cleland JGF, Dickstein K, Lang CC, Ng LL, Ponikowski P, Anker SD, van Veldhuisen DJ, Voors AA, van der Meer P. Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study. Eur J Heart Fail 2021. [PMID: 34816550 DOI: 10.1002/ejhf.2393] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Guazzi M, Generati G, Borlaug B, Alfonzetti E, Sugimoto T, Castelvecchio S, Menicanti L, Bandera F. Redistribution of cardiac output during exercise by functional mitral regurgitation in heart failure: compensatory O 2 peripheral uptake to delivery failure. American Journal of Physiology-Heart and Circulatory Physiology 2020;319:H100-8. [DOI: 10.1152/ajpheart.00125.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Del Buono MG, Mihalick V, Damonte JI, Billingsley H, Vecchiè A, Trankle CR, Kadayira D, Wohlford G, Ho AC, Talasaz A, Carbone S, Markley R, Turlington J, Lu J, Federmann E, Arena R, Van Tassell B, Abbate A, Canada JM. Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection Fraction. Am J Cardiol 2021;158:74-80. [PMID: 34465455 DOI: 10.1016/j.amjcard.2021.07.036] [Reference Citation Analysis]
55 Kirkman DL, Lee DC, Carbone S. Resistance exercise for cardiac rehabilitation. Prog Cardiovasc Dis 2022:S0033-0620(22)00004-4. [PMID: 35122871 DOI: 10.1016/j.pcad.2022.01.004] [Reference Citation Analysis]
56 Legris V, Thibault B, Dupuis J, White M, Asgar AW, Fortier A, Pitre C, Bouabdallaoui N, Henri C, O'Meara E, Ducharme A; EARTH Investigators. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure. ESC Heart Fail 2021. [PMID: 34953062 DOI: 10.1002/ehf2.13726] [Reference Citation Analysis]
57 Bilak JM, Gulsin GS, McCann GP. Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus. Ther Adv Endocrinol Metab 2021;12:2042018820980235. [PMID: 33552463 DOI: 10.1177/2042018820980235] [Reference Citation Analysis]
58 Arenja N, Mueller C, Tomilovskaya E, Koryak Y, Poltavskaya M, Saner H. Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study. Int J Cardiol 2021;344:113-9. [PMID: 34627967 DOI: 10.1016/j.ijcard.2021.09.062] [Reference Citation Analysis]
59 Chiabrando JG, Feola M. Exercise and adverse ventricular remodeling: the cornerstone of heart failure. Minerva Cardiol Angiol 2021;69:435-7. [PMID: 33427422 DOI: 10.23736/S2724-5683.20.05442-0] [Reference Citation Analysis]
60 Taylor JL, Bonikowske AR, Olson TP. Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity. Front Cardiovasc Med 2021;8:734278. [PMID: 34540924 DOI: 10.3389/fcvm.2021.734278] [Reference Citation Analysis]
61 Watanabe K, Yoshihisa A, Sato Y, Hotsuki Y, Anzai F, Ichijo Y, Kimishima Y, Yokokawa T, Misaka T, Sato T, Kaneshiro T, Oikawa M, Kobayashi A, Takeishi Y. Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure. Front Cardiovasc Med 2021;8:631807. [PMID: 33869301 DOI: 10.3389/fcvm.2021.631807] [Reference Citation Analysis]
62 Kirkman DL, Bohmke N, Billingsley HE, Carbone S. Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction. Front Endocrinol (Lausanne) 2020;11:558271. [PMID: 33117276 DOI: 10.3389/fendo.2020.558271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
63 Namani R, Lee LC, Lanir Y, Kaimovitz B, Shavik SM, Kassab GS. Effects of myocardial function and systemic circulation on regional coronary perfusion. J Appl Physiol (1985) 2020;128:1106-22. [PMID: 32078466 DOI: 10.1152/japplphysiol.00450.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Bauldoff GS, Carlin BW. Pulmonary comorbidities in cardiac rehabilitation. Progress in Cardiovascular Diseases 2022. [DOI: 10.1016/j.pcad.2022.01.009] [Reference Citation Analysis]
65 Almeida ILGI, Oliveira LFL, Figueiredo PHS, Oliveira RDB, Damasceno TR, Silva WT, Oliveira LFF, Ávila MR, Lima VP, Lages ATC, Mediano MFF, Rocha MOC, Costa HS. The health-related quality of life in patients with Chagas disease: the state of the art. Rev Soc Bras Med Trop 2022;55:e0657. [PMID: 35293550 DOI: 10.1590/0037-8682-0657-2021] [Reference Citation Analysis]
66 Okamura M, Konishi M, Saigusa Y, Ando S, Nakayama M, Komura N, Sugano T, Tamura K, Nakamura T. Impact of grip strength and gait speed on exercise tolerance in patients with pulmonary hypertension without left heart disease. Heart Vessels 2022. [PMID: 35593926 DOI: 10.1007/s00380-022-02091-2] [Reference Citation Analysis]
67 Peres Valgas da Silva C, Shettigar VK, Baer LA, Abay E, Madaris KL, Mehling MR, Hernandez-Saavedra D, Pinckard KM, Seculov NP, Ziolo MT, Stanford KI. Brown adipose tissue prevents glucose intolerance and cardiac remodeling in high-fat-fed mice after a mild myocardial infarction. Int J Obes (Lond) 2021. [PMID: 34716427 DOI: 10.1038/s41366-021-00999-9] [Reference Citation Analysis]
68 Keir DA, Notarius CF, Badrov MB, Millar PJ, Floras JS. Heart failure-specific inverse relationship between the muscle sympathetic response to dynamic leg exercise and O 2peak. Appl Physiol Nutr Metab 2021;46:1119-25. [DOI: 10.1139/apnm-2020-1074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Bunsawat K, Ratchford SM, Alpenglow JK, Park SH, Jarrett CL, Stehlik J, Smith AS, Richardson RS, Wray DW. Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction. J Appl Physiol (1985) 2021;130:256-68. [PMID: 33211601 DOI: 10.1152/japplphysiol.00454.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Montero D, Diaz-Canestro C. Skeletal Muscle O2 Diffusion and the Limitation of Aerobic Capacity in Heart Failure: A Clarification. Front Cardiovasc Med 2019;6:78. [PMID: 31245387 DOI: 10.3389/fcvm.2019.00078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 LaMonte MJ, Larson JC, Manson JE, Bellettiere J, Lewis CE, LaCroix AZ, Bea JW, Johnson KC, Klein L, Noel CA, Stefanick ML, Wactawski-Wende J, Eaton CB. Association of Sedentary Time and Incident Heart Failure Hospitalization in Postmenopausal Women. Circ Heart Fail 2020;13:e007508. [PMID: 33228398 DOI: 10.1161/CIRCHEARTFAILURE.120.007508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
72 Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Nakamura T, Yamashita M, Uchida S, Maekawa E, Reed JL, Yamaoka-Tojo M, Matsunaga A, Ako J. Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure. Sci Rep 2021;11:3715. [PMID: 33580115 DOI: 10.1038/s41598-020-80641-2] [Reference Citation Analysis]
73 Lavie CJ, Ozemek C, Carbone S, Kachur S. Sustaining Improvements in Cardiorespiratory Fitness and Muscular Strength in Cardiac Rehabilitation. Canadian Journal of Cardiology 2019;35:1275-7. [DOI: 10.1016/j.cjca.2019.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Mihalick V, Wohlford G, Talasaz AH, Ho AJ, Kim F, Canada JM, Carbone S, Kadariya D, Billingsley H, Trankle C, Del Buono MG, Moroni F, Arena R, Abbate A, Van Tassell B. Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure. Am J Cardiol 2022;174:61-7. [PMID: 35473780 DOI: 10.1016/j.amjcard.2022.03.026] [Reference Citation Analysis]
75 Nayor M, Houstis NE, Namasivayam M, Rouvina J, Hardin C, Shah RV, Ho JE, Malhotra R, Lewis GD. Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve Capacity. JACC Heart Fail 2020;8:605-17. [PMID: 32535122 DOI: 10.1016/j.jchf.2020.03.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
76 Salzano A, De Luca M, Israr MZ, Crisci G, Eltayeb M, Debiec R, Ranieri B, D'Assante R, Rega S, D'Agostino A, Mauro C, Squire IB, Suzuki T, Bossone E, Guazzi M, Marra AM. Exercise Intolerance in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 2021;17:397-413. [PMID: 34051972 DOI: 10.1016/j.hfc.2021.03.004] [Reference Citation Analysis]
77 Shirakawa R, Yokota T, Nakajima T, Takada S, Yamane M, Furihata T, Maekawa S, Nambu H, Katayama T, Fukushima A, Saito A, Ishimori N, Dela F, Kinugawa S, Anzai T. Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients. Sci Rep 2019;9:14709. [PMID: 31605012 DOI: 10.1038/s41598-019-51298-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
78 Bozkurt B, Fonarow GC, Goldberg LR, Guglin M, Josephson RA, Forman DE, Lin G, Lindenfeld J, O'Connor C, Panjrath G, Piña IL, Shah T, Sinha SS, Wolfel E; ACC’s Heart Failure and Transplant Section and Leadership Council. Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel. J Am Coll Cardiol 2021;77:1454-69. [PMID: 33736829 DOI: 10.1016/j.jacc.2021.01.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
79 Ma X, Xu X. A Swimming-based Assay to Determine the Exercise Capacity of Adult Zebrafish Cardiomyopathy Models. Bio Protoc 2021;11:e4114. [PMID: 34458408 DOI: 10.21769/BioProtoc.4114] [Reference Citation Analysis]
80 Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2021;18:400-23. [PMID: 33432192 DOI: 10.1038/s41569-020-00480-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
81 Arena R, Canada JM, Popovic D, Trankle CR, Del Buono MG, Lucas A, Abbate A. Cardiopulmonary exercise testing - refining the clinical perspective by combining assessments. Expert Rev Cardiovasc Ther 2020;18:563-76. [PMID: 32749934 DOI: 10.1080/14779072.2020.1806057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Segreti A, Verolino G, Crispino SP, Agostoni P. Listing Criteria for Heart Transplant: Role of Cardiopulmonary Exercise Test and of Prognostic Scores. Heart Fail Clin 2021;17:635-46. [PMID: 34511211 DOI: 10.1016/j.hfc.2021.05.008] [Reference Citation Analysis]
83 Ueno K, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Kawabata M, Maekawa E, Yamaoka-Tojo M, Matsunaga A, Ako J. Usefulness of physical function sub-item of SF-36 survey to predict exercise intolerance in patients with heart failure. Eur J Cardiovasc Nurs 2021:zvab052. [PMID: 34324626 DOI: 10.1093/eurjcn/zvab052] [Reference Citation Analysis]
84 Eslami O, Zarei M, Shidfar F. The association of dietary patterns and cardiorespiratory fitness: A systematic review. Nutr Metab Cardiovasc Dis 2020;30:1442-51. [PMID: 32513576 DOI: 10.1016/j.numecd.2020.04.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Mesquita T, Zhang R, Cho JH, Zhang R, Lin YN, Sanchez L, Goldhaber JI, Yu JK, Liang JA, Liu W, Trayanova NA, Cingolani E. Mechanisms of Sinoatrial Node Dysfunction in Heart Failure With Preserved Ejection Fraction. Circulation 2022;145:45-60. [PMID: 34905696 DOI: 10.1161/CIRCULATIONAHA.121.054976] [Reference Citation Analysis]
86 Franzoni LT, Garcia EL, Motta SB, Ahner MM, Bertoletti OA, Saffi MAL, da Silveira AD, Pereira AA, Pereira AH, Danzmann LC, Stein R. Aerobic exercise and telomere length in patients with systolic heart failure: protocol study for a randomized controlled trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06257-1] [Reference Citation Analysis]
87 Angius L, Crisafulli A. Exercise intolerance and fatigue in chronic heart failure: is there a role for group III/IV afferent feedback? Eur J Prev Cardiol 2020;27:1862-72. [PMID: 32046526 DOI: 10.1177/2047487320906919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
88 D'Amario D, Borovac JA, Crea F. Coronary microvascular dysfunction in heart failure with preserved ejection fraction: not the end but the end of the beginning. Eur J Heart Fail 2021;23:773-5. [PMID: 33247863 DOI: 10.1002/ejhf.2069] [Reference Citation Analysis]
89 Canada JM, Trankle CR, Carbone S, Buckley LF, Chazal M, Billingsley H, Evans RK, Garten R, Van Tassell BW, Kadariya D, Mauro A, Toldo S, Mezzaroma E, Arena R, Hundley WG, Grizzard JD, Weiss E, Abbate A. Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors. Am J Cardiol 2020;125:988-96. [PMID: 31928717 DOI: 10.1016/j.amjcard.2019.12.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
90 Carbone S, Billingsley HE, Canada JM, Kadariya D, Medina de Chazal H, Rotelli B, Potere N, Paudel B, Markley R, Dixon DL, Trankle CR, Van Tassell BW, Celi FS, Abbate A. Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study. JACC Basic Transl Sci 2019;4:563-5. [PMID: 31468011 DOI: 10.1016/j.jacbts.2019.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
91 Carbone S, Billingsley HE, Canada JM, Bressi E, Rotelli B, Kadariya D, Dixon DL, Markley R, Trankle CR, Cooke R, Rao K, B Shah K, Medina de Chazal H, Chiabrando JG, Vecchié A, Dell M, L Mihalick V, Bogaev R, Hart L, Van Tassell BW, Arena R, Celi FS, Abbate A. The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study. Diabetes Metab Res Rev 2020;36:e3335. [PMID: 32415802 DOI: 10.1002/dmrr.3335] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
92 Koshy AO, Gallivan ER, McGinlay M, Straw S, Drozd M, Toms AG, Gierula J, Cubbon RM, Kearney MT, Witte KK. Prioritizing symptom management in the treatment of chronic heart failure. ESC Heart Fail 2020;7:2193-207. [PMID: 32757363 DOI: 10.1002/ehf2.12875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
93 Ueno K, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Yanagi N, Maekawa E, Yamaoka-Tojo M, Matsunaga A, Ako J. Relationship between high-sensitivity cardiac troponin T, B-type natriuretic peptide, and physical function in patients with heart failure. ESC Heart Fail 2021. [PMID: 34490747 DOI: 10.1002/ehf2.13577] [Reference Citation Analysis]
94 Del Buono MG, Bonaventura A, Vecchié A, Wohlford GF, Dixon DL, Van Tassel BW, Abbate A. Sacubitril–Valsartan for the Treatment of Heart Failure: Time for a Paragon? Journal of Cardiovascular Pharmacology 2020;75:105-7. [DOI: 10.1097/fjc.0000000000000782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
95 Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, Binder L, Düngen HD, Hasenfuss G, Pieske B, Wachter R, Edelmann F. Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc 2020;28:100525. [PMID: 32420447 DOI: 10.1016/j.ijcha.2020.100525] [Reference Citation Analysis]
96 Udelson JE, Lewis GD, Shah SJ, Zile MR, Redfield MM, Burnett J Jr, Mittleman RS, Profy AT, Seferovic JP, Reasner D, Konstam MA. Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF). Am Heart J 2020;222:183-90. [PMID: 32105984 DOI: 10.1016/j.ahj.2020.01.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
97 daSilva-deAbreu A, Alhafez BA, Curbelo-Pena Y, Lavie CJ, Ventura HO, Loro-Ferrer JF, Mandras SA. Bariatric Surgery in Patients with Obesity and Ventricular Assist Devices Considered for Heart Transplantation: Systematic Review and Individual Participant Data Meta-analysis. J Card Fail 2021;27:338-48. [PMID: 33358959 DOI: 10.1016/j.cardfail.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Badrov MB, Mak S, Floras JS. Cardiovascular Autonomic Disturbances in Heart Failure With Preserved Ejection Fraction. Can J Cardiol 2021;37:609-20. [PMID: 33310140 DOI: 10.1016/j.cjca.2020.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Mei D, Tan WSD, Tay Y, Mukhopadhyay A, Wong WSF. Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease. Trends Pharmacol Sci 2020;41:475-86. [PMID: 32434654 DOI: 10.1016/j.tips.2020.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
100 Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL, Lee DC, Lavie CJ. Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia. Curr Probl Cardiol 2020;45:100417. [PMID: 31036371 DOI: 10.1016/j.cpcardiol.2019.03.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
101 Clark HI, Pearson MJ, Smart NA. Rate adaptive pacing in people with chronic heart failure increases peak heart rate but not peak exercise capacity: a systematic review. Heart Fail Rev 2022. [PMID: 35138522 DOI: 10.1007/s10741-022-10217-x] [Reference Citation Analysis]
102 Aronow WS, Lloji A, Sreenivasan J, Novograd J, Pan S, Lanier GM. Heart failure with preserved ejection fraction: key stumbling blocks for experimental drugs in clinical trials. Expert Opin Investig Drugs 2022. [PMID: 35443138 DOI: 10.1080/13543784.2022.2069009] [Reference Citation Analysis]
103 Corrieri N, Del Torto A, Vignati C, Maragna R, De Martino F, Cellamare M, Farina S, Salvioni E, Bonomi A, Agostoni P. Cardiac output changes during exercise in heart failure patients: focus on mid-exercise. ESC Heart Fail 2021;8:55-62. [PMID: 33201613 DOI: 10.1002/ehf2.13005] [Reference Citation Analysis]
104 Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, Niccoli G, Crea F. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:1352-71. [PMID: 34556322 DOI: 10.1016/j.jacc.2021.07.042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Hamazaki N, Kamiya K, Yamamoto S, Nozaki K, Ichikawa T, Matsuzawa R, Tanaka S, Nakamura T, Yamashita M, Maekawa E, Meguro K, Noda C, Yamaoka-Tojo M, Matsunaga A, Ako J. Changes in Respiratory Muscle Strength Following Cardiac Rehabilitation for Prognosis in Patients with Heart Failure. J Clin Med 2020;9:E952. [PMID: 32235491 DOI: 10.3390/jcm9040952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
106 Zhou ZF, Wang DJ, Li XM, Zhang CL, Wu CY. Effects of enhanced external counterpulsation on exercise capacity and quality of life in patients with chronic heart failure: A meta-analysis. Medicine (Baltimore) 2021;100:e26536. [PMID: 34232191 DOI: 10.1097/MD.0000000000026536] [Reference Citation Analysis]
107 Kagiyama N, Toki M, Yuri T, Aritaka S, Hayashida A, Sengupta PP, Yoshida K. Physiological and prognostic differences between types of exercise stress echocardiography for functional mitral regurgitation. Open Heart 2021;8:e001583. [PMID: 33888592 DOI: 10.1136/openhrt-2021-001583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Saw EL, Ramachandran S, Valero-Muñoz M, Sam F. Skeletal muscle (dys)function in heart failure with preserved ejection fraction. Curr Opin Cardiol 2021;36:219-26. [PMID: 33394707 DOI: 10.1097/HCO.0000000000000824] [Reference Citation Analysis]
109 Fukata M. Acute Decompensated Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction. Heart Fail Clin 2020;16:187-200. [PMID: 32143763 DOI: 10.1016/j.hfc.2019.12.007] [Reference Citation Analysis]
110 Szalewska D, Główczyńska R, Piotrowicz R, Kowalik I, Pencina MJ, Opolski G, Zaręba W, Banach M, Orzechowski P, Pluta S, Irzmański R, Kalarus Z, Piotrowicz E. An aetiology-based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) trial. ESC Heart Fail 2021;8:1263-73. [PMID: 33527740 DOI: 10.1002/ehf2.13189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 LaMonte MJ, Eaton CB. Physical Activity in the Treatment and Prevention of Heart Failure: An Update. Curr Sports Med Rep 2021;20:410-7. [PMID: 34357887 DOI: 10.1249/JSR.0000000000000869] [Reference Citation Analysis]